---
figid: PMC9400130__etm-24-03-11500-g00
pmcid: PMC9400130
image_filename: etm-24-03-11500-g00.jpg
figure_link: /pmc/articles/PMC9400130/figure/f1-ETM-24-3-11500/
number: Figure 1
figure_title: ''
caption: Flow chart of the work on screening and identifying a key gene associated
  with biochemical recurrence of prostate cancer and validating some potential biological
  functions. PCa, prostate cancer; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of
  Genes and Genomes; DO, Disease Ontology; DEGs, differentially expressed genes; Lasso,
  least absolute shrinkage and selection operator; SVM-RFE, support vector machine
  with recursive feature elimination; PPI, protein-protein interaction; MCODE, molecular
  complex detection; GSEA, gene set enrichment analysis; ROC, receiver operating characteristic;
  TCGA, The Cancer Genome ATLAS; PRAD, prostate adenocarcinoma; LTBP2, latent transforming
  growth factor Î²-binding protein 2; ceRNA, competitive endogenous RNA; TME, tumor
  microenvironment.
article_title: LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT
  signaling pathway.
citation: Xiaowen Zhang, et al. Exp Ther Med. 2022 Sep;24(3):563.
year: '2022'

doi: 10.3892/etm.2022.11500
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- prostate cancer
- The Cancer Genome Atlas
- Gene Expression Omnibus
- tumor microenvironment
- immunotherapy
- LTBP2

---
